A Double-masked Placebo-controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ONO-9054 in Healthy Adult Subjects
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Sepetaprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions
- Sponsors Ono Pharmaceutical
- 12 Jun 2014 New trial record